In silco studies on modified hydroxamic acid and valporic acid as potential inhibitors for HDAC2
Histone deacetylases2, Class 1 HDAC family are emerged as an important therapeutic target for the treatment of various cancers. HDAC2 inhibitors are potent anti-cancer agents. Two inhibitors of HDAC2 are Hydroxamic acid and Valporic acid which are potent inducers of growth arrest, differentiation, a...
Sábháilte in:
Príomhchruthaitheoirí: | , , , |
---|---|
Formáid: | LEABHAR |
Foilsithe / Cruthaithe: |
Bangladesh Pharmacological Society,
2013-08-01T00:00:00Z.
|
Ábhair: | |
Rochtain ar líne: | Connect to this object online. |
Clibeanna: |
Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|
Ar líne
Connect to this object online.3rd Floor Main Library
Gairmuimhir: |
A1234.567 |
---|---|
Cóip 1 | Ar fáil |